Cargando…
Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope”
Autores principales: | Singh, Padam, Kumar, Shashi Kant, Maurya, Vineet Kumar, Mehta, Basant Kumar, Ahmad, Hafsa, Dwivedi, Anil Kumar, Chaturvedi, Vinita, Thakur, Tejender S., Sinha, Sudhir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645526/ https://www.ncbi.nlm.nih.gov/pubmed/31457441 http://dx.doi.org/10.1021/acsomega.7b01966 |
Ejemplares similares
-
S-Enantiomer of the Antitubercular Compound
S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis
of Mycobacterium tuberculosis Cell
Envelope
por: Singh, Padam, et al.
Publicado: (2017) -
The R Enantiomer of the Antitubercular Drug PA-824 as a Potential Oral Treatment for Visceral Leishmaniasis
por: Patterson, Stephen, et al.
Publicado: (2013) -
Natural Enantiomers: Occurrence, Biogenesis and Biological Properties
por: Yu, Jin-Hai, et al.
Publicado: (2022) -
A study of C-reactive protein and D-dimer in patients of appendicitis
por: Kumar, Satendra, et al.
Publicado: (2020) -
Naturally produced opsonizing antibodies restrict the survival of Mycobacterium tuberculosis in human macrophages by augmenting phagosome maturation
por: Kumar, Shashi Kant, et al.
Publicado: (2015)